TABLE 6.

Properties comparison of the representative products of four companies.

Company	Graft	Burst pressure (mmHg)	Suture retention strength (gf)	Ultimate tensile strength (MPa)	Compliance (%)	Primary patency
Cytograft Tissue Engineering Inc.	Lifeline™	3,486 ± 500	162 ± 15	Not mentioned	1.5 ± 0.3	66.7% for 13 months
Humacyte, Inc.	Human acellular vessels (HAVs)	2,914 ± 928	440 ± 85	Not mentioned	Not mentioned	89% for 1 year
Vascudyne, Inc.	Arteriovenous graft (AVG)	3,164 ± 342	199 ± 56	3.8 ± 0.7	Not mentioned	60% for 6 months
LeMaitre Vascular, Inc.	Artegraft®	2,422 ± 354	Not mentioned	Not mentioned	3.3 ± 0.9	73.3% for 1 year